Jennifer Kim

Proteomic signature predicts the metastatic risk of primary cutaneous squamous cell carcinomas.

Cutaneous squamous cell carcinoma (cSCC) is a heterogeneous skin malignancy worldwide. While most tumours are effectively treated by surgical excision, between 5% and 37% of biologically aggressive cases metastasise to regional lymph nodes or distant organs. Identifying tumours at risk of metastasis remains challenging...